NASDAQ : HIND
Vyome Holdings, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.28M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 12.63M |
| Enterprise Value | 4.76M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 7.02M |
| Shares Outstanding | 7.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +4.91% |
| Owned by Insiders (%) | 11.20% |
| Owned by Institutions (%) | 6.99% |
| Float | 3.65M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 97.39 |
| Forward PS | n/a |
| PB Ratio | 2.09 |
| P/TBV Ratio | 2.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 36.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.37 |
| Quick Ratio | 4.31 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -101.07 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -999.17% |
| Return on Assets (ROA) | -48.79% |
| Return on Invested Capital (ROIC) | -77.04% |
| Return on Capital Employed (ROCE) | -57.67% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $9,266 |
| Profits Per Employee | -$807,696 |
| Employee Count | 14 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -66.54% |
| 50-Day Moving Average | 2.00 |
| 200-Day Moving Average | 2.25 |
| Relative Strength Index (RSI) | 40.89 |
| Average Volume (20 Days) | 10,909 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 20,677 |
| Short Previous Month | 26,227 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 0.57% |
| Short Ratio (days to cover) | 1.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 129,725 |
| Gross Profit | 68,420 |
| Operating Income | -4.22M |
| Pretax Income | -11.58M |
| Net Income | -11.31M |
| EBITDA | -4.21M |
| EBIT | -4.22M |
| Loss Per Share | -$1.61 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 7.89M |
| Total Debt | 17,310 |
| Net Cash | 7.87M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 7.31M |
| Book Value Per Share | 0.86 |
| Working Capital | 6.29M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.58M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 10,709 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.58M |
| FCF Per Share | -$0.79 |
Margins
| Measure | Value |
|---|
| Gross Margin | 52.74% |
| Operating Margin | -3,250.23% |
| Pretax Margin | -8,926.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -89.51% |
| FCF Yield | -44.16% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.83 |
| Price Target Difference | 390.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -6.76 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |